- Home
- ROIV vs SIRI Comparison
ROIV vs SIRI Comparison
Compare ROIV & SIRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ROIV
- SIRI
- Stock Information
- Founded
- ROIV 2014
- SIRI 2013
- Country
- ROIV United Kingdom
- SIRI United States
- Employees
- ROIV N/A
- SIRI N/A
- Industry
- ROIV Biotechnology: Pharmaceutical Preparations
- SIRI Broadcasting
- Sector
- ROIV Health Care
- SIRI Consumer Discretionary
- Exchange
- ROIV Nasdaq
- SIRI Nasdaq
- Market Cap
- ROIV 8.6B
- SIRI 7.8B
- IPO Year
- ROIV N/A
- SIRI 1994
- Fundamental
- Price
- ROIV $16.66
- SIRI $21.56
- Analyst Decision
- ROIV Strong Buy
- SIRI Buy
- Analyst Count
- ROIV 8
- SIRI 12
- Target Price
- ROIV $19.94
- SIRI $27.00
- AVG Volume (30 Days)
- ROIV 8.3M
- SIRI 3.2M
- Earning Date
- ROIV 11-11-2025
- SIRI 10-30-2025
- Dividend Yield
- ROIV N/A
- SIRI 4.96%
- EPS Growth
- ROIV N/A
- SIRI N/A
- EPS
- ROIV N/A
- SIRI N/A
- Revenue
- ROIV $23,233,000.00
- SIRI $8,565,000,000.00
- Revenue This Year
- ROIV N/A
- SIRI N/A
- Revenue Next Year
- ROIV $200.91
- SIRI N/A
- P/E Ratio
- ROIV N/A
- SIRI N/A
- Revenue Growth
- ROIV N/A
- SIRI N/A
- 52 Week Low
- ROIV $8.73
- SIRI $18.69
- 52 Week High
- ROIV $16.79
- SIRI $29.18
- Technical
- Relative Strength Index (RSI)
- ROIV 78.13
- SIRI 41.02
- Support Level
- ROIV $15.91
- SIRI $20.89
- Resistance Level
- ROIV $16.39
- SIRI $22.99
- Average True Range (ATR)
- ROIV 0.48
- SIRI 0.73
- MACD
- ROIV -0.02
- SIRI -0.15
- Stochastic Oscillator
- ROIV 92.05
- SIRI 21.14
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About SIRI Sirius XM Holdings Inc.
Sirius XM operates almost exclusively in the US through its SiriusXM and Pandora audio services. SiriusXM is primarily a satellite radio service that offers nationwide coverage and mostly ad-free listening, with proprietary channels and exclusive content. It makes agreements with automakers to install its radios in vehicles and give trial services to vehicle buyers, which have traditionally fed its subscriber base. The company provides the service through a handful of geostationary satellites that it owns and operates; it now offers a streaming SiriusXM option as well. Pandora, which makes up a much smaller portion of revenue and profit, offers a subscription and ad-supported streaming music service that competes with industry giants like Spotify, Apple Music, and YouTube Music.